Ontology highlight
ABSTRACT: Background
Beta blockers (BBs) are a cornerstone for patients with heart failure (HF) and ventricular dysfunction. However, their use in patients recovering from a cardiogenic shock (CS) remains a bone of contention, especially regarding whether and when to reintroduce this class of drugs.Methods
FRENSHOCK is a prospective multicenter registry including 772 CS patients from 49 centers. Our aim was to compare outcomes (1-month and 1-year all-cause mortality) between CS patients taking and those not taking BBs in three scenarios: (1) at 24 h after CS; (2) patients who did or did not discontinue BBs within 24 h; and (3) patients who did or did not undergo the early introduction of BBs.Results
Among the 693 CS included, at 24 h after the CS event, 95 patients (13.7%) we
SUBMITTER: Cardelli LS
PROVIDER: S-EPMC10747751 | biostudies-literature | 2023 Dec
REPOSITORIES: biostudies-literature